ALL QUESTIONS ARE FOR CANADA LAW

\fA SNDS is submitted in order to obtain a licence to market 3 SEE. \fWhich Regulations apply to the following CBP if they are not combined with non-tissue product: Autologous, minimal manipulation, homologous use, no systemic effects/metabolic activity 0 No Regulations O Food and Drug Regulations 0 Cell Tissue and Organ Regulations Two of the most important considerations during the manufacture of a biologic are _____________ in production and _____________ of contamination. Blank#2[ ] A\\/ Schedule B drugs undergo both pre and post market lot release testing